Treatment

Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?
As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised to greatly benefit from the...
June 20th marks World Psychedelic Day, and for Australians it has special significance psychedelic-assisted therapies in Australia this year....
Warriors of Consciousness helps individuals struggling with anxiety, PTSD and depression to get access to free ketamine therapy....
The largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant depression (TRD) has finally begun....
A single 25mg dose of psilocybin paired with psychological support has resulted in 57% of patients....
MEAI seems to function like an “enough switch” in the brain, stopping all further desire for alcohol or cocaine and...
A non-hallucinogenic LSD analogue may be able to treat mood disorders and chronic stress without the hallucinations....
Taking an objective look at Oregon's first licensed psilocybin center costs. Is $2800 - $3500 for one session justifiable?...
The psychedelic news scene continues to be constantly evolving, with new developments emerging from various states across the country....
Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies....